A starch-digesting enzyme from yeast that helps break down carbohydrates in your gut. Breaks down starches (amylose and amylopectin) into maltose and dextrins for easier absorption. Pre-digests carbohydrates before they reach your small intestine.
Reviewed March 2026
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Diastase has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Diastase was the nineteenth-century term for the starch-splitting activity now resolved into alpha-amylase, beta-amylase and glucoamylase. A product declaring both diastase and amylase is declaring overlapping activity rather than two separate tools. Total activity is what matters, and it is measured in units rather than milligrams.
Pancreatin is a mixed extract carrying amylase, protease and lipase from pancreatic tissue. Its amylase works at the near-neutral pH of the small intestine, while microbial diastase preparations retain activity at lower pH. Taken together they cover a wider pH span of the meal transit than either does alone.
Mixed enzyme products pair amylolytic, proteolytic and lipolytic activity because a normal meal contains all three macronutrient classes. Diastase covers only the starch fraction. The pairing is formulation convention and reflects meal composition rather than any interaction between the enzymes themselves.
Lipase hydrolyses ester bonds in triglycerides while amylolytic enzymes hydrolyse glycosidic bonds in starch. The two cannot compete because their substrates and their chemistries differ. Combining them broadens macronutrient coverage in a single capsule.
Lactase cleaves the beta-1,4 bond in lactose, a linkage amylases cannot touch. Amylase cleaves alpha-1,4 bonds in starch, which lactase cannot touch. Blends carry both because the two carbohydrate complaints people report come from different sugars.
Pepsin needs a strongly acidic pH and is a protease, so it can hydrolyse other proteins including enzymes. Amylases are themselves proteins and lose activity under gastric acid and pepsin exposure. A blend carrying both is relying on transit and on the enzymes' relative acid stability, which differs between fungal, bacterial and cereal sources.
Betaine hydrochloride lowers gastric pH, which suits pepsin and acid-stable fungal amylases but shortens the working life of cereal or pancreatic amylase. The source of the amylolytic activity therefore decides whether the pairing helps or hinders. Read the interaction as source-specific rather than uniform across all starch enzymes.
Alpha-amylases hold one or more tightly bound calcium ions that stabilise the tertiary fold near the active site. Removing that calcium with a chelator unfolds and inactivates the enzyme. This is a structural requirement of the enzyme in the vial rather than a reason to dose calcium with a meal.
Resistant starch resists amylolytic digestion because of its crystalline packing, retrogradation or chemical modification, which is exactly why it reaches the colon and feeds fermentation. Adding an amylolytic enzyme can degrade part of some resistant starch types, converting fermentable substrate into absorbable glucose upstream. The two work against each other by design.
Green tea catechins bind alpha-amylase and inhibit its activity in laboratory assays. Taken in the same capsule or the same meal they work against added amylolytic activity. The inhibition is well characterised in vitro; how much of it survives in a real meal is less clear.
1-Deoxynojirimycin is a sugar-mimicking inhibitor of intestinal alpha-glucosidases, the enzymes that finish the job amylase starts. Pairing it with an added starch-splitting enzyme sets two ingredients against each other on the same digestive sequence. Anyone taking both is paying for opposing actions.
Phytase releases phosphate from phytic acid and in doing so frees minerals that phytate had bound. It is often produced by the same fungal fermentation platforms used for microbial amylases and appears alongside them in blends. The two act on different substrates and the pairing is a manufacturing and formulation convention.
Bromelain is a cysteine protease acting on peptide bonds, a chemistry unrelated to glycosidic bond hydrolysis. Blends include both to cover protein and starch in the same meal. A caveat worth stating: proteases in a blend can degrade the other enzymes over shelf life if the formulation does not separate or stabilise them.
Talk to a doctor before taking Diastase if any of these apply to you: Most healthy people don't need supplemental amylase, Not for people with yeast allergies. These are flags to check first, not effects Diastase is known to cause.
Not medical advice. Show the label to your pharmacist.The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
These are the studies our verdict leans on, chosen from the 2 we read for Diastase. The full linked list is below.
Read this carefully. These are 493 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Diastase is, not how risky it is. A report is not proof Diastase caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.